Atlas Trials

Autologous Dendritic Cell Therapy for Type 1 Diabetes Suppression: A Safety Study

Clinical trial NCT00445913 · COMPLETED

Trial details

NCT number
NCT00445913
Sponsor
University of Pittsburgh
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 1 Diabetes
Start date
2007-03-01
Primary completion
2012-01-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.